We are live on ! Find out more
TXG icon

10x Genomics
TXG

314 hedge funds and large institutions have $6.29B invested in 10x Genomics in 2022 Q1 according to their latest regulatory filings, with 50 funds opening new positions, 135 increasing their positions, 72 reducing their positions, and 96 closing their positions.

New
Increased
Maintained
Reduced
Closed

88% more repeat investments, than reductions

Existing positions increased: 135 | Existing positions reduced: 72

1.43% more ownership

Funds ownership: 87.32% → 88.75% (+1.4%)

11% less funds holding in top 10

Funds holding in top 10: 9 → 8 (-1)

14% less funds holding

Funds holding: 365 → 314 (-51)

35% less call options, than puts

Call options by funds: $20.5M | Put options by funds: $31.7M

47% less capital invested

Capital invested by funds: $11.9B → $6.29B (-$5.58B)

48% less first-time investments, than exits

New positions opened: 50 | Existing positions closed: 96

Holders
314
Holders Change
-51
Holders Change %
-13.97%
% of All Funds
4.95%
Holding in Top 10
8
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-11.11%
% of All Funds
0.13%
New
50
Increased
135
Reduced
72
Closed
96
Calls
$20.5M
Puts
$31.7M
Net Calls
-$11.2M
Net Calls Change
-$3.96M

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$389M
2
Sands Capital Management
Sands Capital Management
Virginia
+$134M
3
BlackRock
BlackRock
New York
+$99.6M
4
AIM
ARK Investment Management
Florida
+$63.9M
5
1WCM
12 West Capital Management
New York
+$45M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$268M
2
DCP
D1 Capital Partners
New York
-$239M
3
William Blair Investment Management
William Blair Investment Management
Illinois
-$159M
4
JCM
JS Capital Management
New York
-$80.5M
5
AllianceBernstein
AllianceBernstein
Tennessee
-$68.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
William Blair Investment Management
301
William Blair Investment Management
Illinois
– -$159M -1,066,422 Closed
JCM
302
JS Capital Management
New York
– -$80.5M -540,589 Closed
Point72 Asset Management
303
Point72 Asset Management
Connecticut
– -$25.5M -171,462 Closed
T
304
TOBAM
France
– -$23.8M -159,729 Closed
Allianz Asset Management
305
Allianz Asset Management
Germany
– -$21M -141,261 Closed
PCH
306
Polar Capital Holdings
United Kingdom
– -$16.1K -108,063 Closed
Jennison Associates
307
Jennison Associates
New York
– -$13.8M -92,476 Closed
PI
308
Putnam Investments
Massachusetts
– -$13.6M -91,028 Closed
Fidelity International
309
Fidelity International
Bermuda
– -$10.3M -68,816 Closed
CG
310
Carmignac Gestion
France
– -$10.1M -67,623 Closed
SLG
311
Stanley-Laman Group
Pennsylvania
– -$9.93M -66,643 Closed
PCA
312
Personal Capital Advisors
California
– -$9.48M -63,623 Closed
ACMH
313
Andar Capital Management (HK)
Hong Kong
– -$8.19M -55,000 Closed
Susquehanna International Group
314
Susquehanna International Group
Pennsylvania
– -$3.7M -42,291 Closed
E
315
Ergoteles
New York
– -$4.27M -28,666 Closed
PP
316
PDT Partners
New York
– -$4.11M -27,573 Closed
Victory Capital Management
317
Victory Capital Management
Texas
– -$3.51M -23,560 Closed
SCM
318
Shelton Capital Management
Colorado
– -$2.88M -19,300 Closed
Jane Street
319
Jane Street
New York
– -$1.35M -15,433 Closed
Prudential Financial
320
Prudential Financial
New Jersey
– -$1.95M -12,850 Closed
VIA
321
Vident Investment Advisory
Georgia
– -$1.81M -12,147 Closed
Mariner
322
Mariner
Kansas
– -$1.75M -11,758 Closed
Marshall Wace
323
Marshall Wace
United Kingdom
– -$1.45M -9,704 Closed
JIP
324
Jaffetilchin Investment Partners
Florida
– -$1.41M -9,433 Closed
PA
325
Paragon Advisors
Texas
– -$1.39M -9,315 Closed
11 12
13
14 15

TXG Hedge Fund Activity: Q1 2022 in Review

314 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in 10x Genomics (TXG) for Q1 2022, worth a combined $6.29B — down 47% from $11.9B a quarter earlier.

Sellers outnumbered buyers: 96 funds closed out of TXG and 50 opened new positions — a net loss of 46 holders — while 72 trimmed existing stakes and 135 added.

The largest buyer was Morgan Stanley, adding an estimated $389M. The largest seller was Fidelity Investments, cutting an estimated $268M.

  • 314 institutional investors held 10x Genomics (TXG) as of Q1 2022, down from 365 in Q4 2021.
  • Funds reported $6.29B of 10x Genomics stock for Q1 2022, down 47% quarter-over-quarter.
  • 50 funds opened new 10x Genomics positions in Q1 2022 and 96 closed out, a net change of -46 holders.
  • The largest 10x Genomics buyer in Q1 2022 was Morgan Stanley, an estimated $389M added.
  • The largest 10x Genomics seller in Q1 2022 was Fidelity Investments, an estimated $268M sold.

Based on aggregated 13F filings for Q1 2022.